Actualités Ampio Pharmaceuticals Inc (CE) - AMPE | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K ...

- Amended Current report filing (8-K/A)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K ...

- Withdrawal of Registration Statement (RW)

Ampio Pharmaceuticals, Inc. 5445 DTC Parkway, P4 Greenwood Village, Colorado 80111 January 6, 2011 VIA EDGAR United States Securities...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...

- Securities Registration Statement (S-1)

Table of Contents As filed with the Securities and Exchange Commission on November 12, 2010...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Amended Current report filing (8-K/A)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) ...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE...

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., July 27 GREENWOOD VILLAGE...

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™ PR Newswire GREENWOOD VILLAGE, Colo., July 21 GREENWOOD VILLAGE...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer PR Newswire GREENWOOD VILLAGE, Colo., May 10 GREENWOOD VILLAGE...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE)

Outils de qualité professionnelle, pour des investisseurs individuels.

AMPE Actualités

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Amended Current report filing (8-K/A)

- Withdrawal of Registration Statement (RW)

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Amended Current report filing (8-K/A)

- Quarterly Report (10-Q)

- Current report filing (8-K)

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™

- Quarterly Report (10-Q)

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE) Actualités

Ampio Pharmaceuticals Inc (CE) (AMPE)

Outils de qualité professionnelle, pour des investisseurs individuels.

AMPE Actualités

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Amended Current report filing (8-K/A)

- Withdrawal of Registration Statement (RW)

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Amended Current report filing (8-K/A)

- Quarterly Report (10-Q)

- Current report filing (8-K)

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™

- Quarterly Report (10-Q)

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités